Ravulizumab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial
New England Journal of Medicine, Volume 395, Issue 19, Page 1921-1931, November 12, 2026.
We haven't written up this one. NEJM has the full story — the link below goes straight to it.